COHLHEPP RYAN (President and COO) sold 9.4% of their position (18.75K shares) of BICARA THERAPEUTICS INC. on the open market
Open‑market sale worth $524.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/12/2026ACC: 0001470831-26-000812
DirectorOfficer· President and COO
Since Mar 2026
-18.75K
Net shares
Net seller
$524.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
18.75K acquired · 37.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+18.75K
Price / share
$3.79
Trade value
$71.06K
% of position
10.3%
8/10/2026
181.64K→200.39K
Common Stock
Direct
Shares
−18.75K
Price / share
$27.98
Trade value
$524.53K
% of position
9.4%
8/10/2026
200.39K→181.64K
Total
Net shares
+0.00
Net value
-$453.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2026 | M · Option Exercise | +18.75K | $3.79 | $71.06K | 10.3% | 181.64K | 200.39K |
| Common Stock Direct | 8/10/2026 | S · Sale | −18.75K | $27.98 | $524.53K | 9.4% | 200.39K | 181.64K |
| Total | +0.00 | -$453.47K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
18.75K shares
Shares
−18.75K
Strike price
3.7898
Held after
51.75K
Exercisable
—
8/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock18.75K shares | 8/10/2026 | M · Option Exercise | −18.75K | 3.7898 | — | 51.75K |